ICU Medical Inc. announced on April 7, 2025, that it received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its Plum Solo™ precision IV pump, a single-channel device. The company also secured 510(k) clearance for updated versions of its dual-channel Plum Duo™ precision IV pump and LifeShield™ infusion safety software, marking the initial launch of the ICU Medical IV Performance Platform.
These new precision IV pumps are designed to address infusion delivery variability, offering a stated ±3% delivery accuracy regardless of external factors such as medication bag placement or patient orientation. This technology is built on the unique cassette system of the Best in KLAS award-winning Plum 360™, providing clinicians with predictable performance and reliable infusion documentation.
The introduction of these new devices represents a critical step forward for infusion therapy, aiming to set a new standard for accuracy and safety. ICU Medical plans to integrate its Medfusion syringe and CADD ambulatory pumps onto the common LifeShield platform, creating a unified fleet of infusion devices and anchoring future revenue growth.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.